ArticleScientific reports2022

Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy.

Ruan F V Medrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.